DAFNA Capital Management as of June 30, 2014
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 49 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ampio Pharmaceuticals | 11.1 | $12M | 1.4M | 8.35 | |
| AtriCure (ATRC) | 9.9 | $11M | 571k | 18.38 | |
| Pharmacyclics | 9.8 | $10M | 116k | 89.71 | |
| Discovery Laboratories | 9.6 | $10M | 5.7M | 1.78 | |
| NxStage Medical | 5.2 | $5.5M | 384k | 14.37 | |
| Stereotaxis (STXS) | 4.7 | $4.9M | 1.4M | 3.55 | |
| Derma Sciences | 4.2 | $4.4M | 385k | 11.56 | |
| Novadaq Technologies | 4.1 | $4.3M | 264k | 16.48 | |
| Insulet Corporation (PODD) | 4.1 | $4.3M | 109k | 39.67 | |
| Protalix BioTherapeutics | 4.1 | $4.3M | 1.2M | 3.65 | |
| Insulet Corp note 2.000% 6/1 | 2.5 | $2.7M | 2.4M | 1.11 | |
| Biota Pharmaceuticals | 2.0 | $2.1M | 730k | 2.85 | |
| Galmed Pharmaceuticals | 1.9 | $2.0M | 206k | 9.74 | |
| BioSpecifics Technologies | 1.8 | $1.9M | 70k | 26.97 | |
| Cardica | 1.6 | $1.7M | 1.5M | 1.14 | |
| Biotelemetry | 1.6 | $1.7M | 236k | 7.17 | |
| Threshold Pharmaceuticals | 1.5 | $1.6M | 393k | 3.96 | |
| Venaxis | 1.4 | $1.5M | 658k | 2.23 | |
| Alcobra | 1.4 | $1.5M | 85k | 17.31 | |
| Keryx Biopharmaceuticals | 1.4 | $1.4M | 92k | 15.38 | |
| Ocera Therapeutics | 1.2 | $1.2M | 161k | 7.64 | |
| Uroplasty | 1.1 | $1.2M | 442k | 2.68 | |
| XenoPort | 1.1 | $1.2M | 240k | 4.83 | |
| Nuvasive Inc. conv | 1.1 | $1.2M | 1.0M | 1.15 | |
| Encision | 1.1 | $1.1M | 1.1M | 1.06 | |
| Johnson & Johnson (JNJ) | 0.9 | $983k | 9.4k | 104.57 | |
| Spectranetics Corporation | 0.9 | $965k | 42k | 22.89 | |
| Syneron Medical Ltd ord | 0.9 | $939k | 91k | 10.32 | |
| Cytrx | 0.9 | $941k | 225k | 4.18 | |
| Cutera (CUTR) | 0.9 | $922k | 89k | 10.40 | |
| Exactech | 0.8 | $798k | 32k | 25.22 | |
| RTI Biologics | 0.7 | $727k | 167k | 4.35 | |
| Intercept Pharmaceuticals In | 0.5 | $473k | 2.0k | 236.50 | |
| Fate Therapeutics (FATE) | 0.5 | $479k | 76k | 6.31 | |
| Lpath | 0.4 | $417k | 105k | 3.97 | |
| Masimo Corporation (MASI) | 0.4 | $413k | 18k | 23.60 | |
| Ardelyx (ARDX) | 0.4 | $399k | 25k | 15.96 | |
| Scynexis | 0.4 | $401k | 50k | 8.02 | |
| Tonix Pharmaceuticls | 0.3 | $359k | 25k | 14.36 | |
| Curis | 0.3 | $279k | 150k | 1.86 | |
| Celsus Therapeutics Plc sponsored adr ne | 0.3 | $272k | 44k | 6.20 | |
| Biolife Solutions (BLFS) | 0.2 | $265k | 116k | 2.28 | |
| Genvec | 0.2 | $257k | 100k | 2.57 | |
| Inspiremd | 0.2 | $248k | 84k | 2.94 | |
| Regado Biosciences | 0.2 | $204k | 30k | 6.80 | |
| Chembio Diagnostics | 0.2 | $189k | 55k | 3.42 | |
| Lumenis Ltd shs cl b | 0.1 | $92k | 9.5k | 9.71 | |
| Northwest Biotherapeutics In (NWBO) | 0.1 | $81k | 12k | 6.74 | |
| Retractable Technologies (RVP) | 0.1 | $50k | 20k | 2.50 |
